Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergen microarrays.

Tito Bacarese-Hamilton1, Julian Gray, Andrea Ardizzoni

  • 1Department of Biological Sciences, Imperial College London, London, UK.

Methods in Molecular Medicine
|September 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: The "atoll sign": a case series on an unusual radiological pattern of immune-mediated pneumonitis.

Frontiers in immunology·2026
Same author

Cancer of unknown primary genomic profiling from cell-free DNA provides insights into CUP biology and vulnerabilities.

Frontiers in medicine·2026
Same author

Management of periungual pyogenic granulomas due to EGFR inhibitors in real world.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression: A Systematic Review and Meta-Analysis.

JAMA oncology·2026
Same author

Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Efficacy of Adding Immune Checkpoint Inhibition to Chemotherapy, With or Without VEGF Inhibition, in Patients With Advanced <i>EGFR</i>-Mutated NSCLC: A Systematic Review and Meta-Analysis With Reconstructed Individual Patient Data.

JTO clinical and research reports·2026

Protein microarrays offer a timely, cost-effective solution for diagnosing allergies by detecting multiple allergens in patient serum. These advanced assays provide significant advantages over traditional methods for allergy diagnosis.

Area of Science:

  • Immunology
  • Biotechnology
  • Medical Diagnostics

Background:

  • Allergies impact over 25% of Western populations, representing a significant public health concern.
  • Current diagnostic methods for allergies face limitations in efficiency, cost, and timeliness.
  • There is a clinical need for assays capable of simultaneous, efficient determination of multiple allergens.

Purpose of the Study:

  • To detail the development and application of allergen microarrays for allergy serodiagnosis.
  • To provide an overview of protein microarray technology for clinical diagnostics.
  • To discuss the principles of using protein microarrays for serum profiling in allergic disease.

Main Methods:

  • Development of miniaturized immunoassays utilizing protein microarray technology.

Related Experiment Videos

  • Immobilization of capture molecules and detection of bound ligands on the array.
  • Addressing challenges in protein stabilization and the absence of amplification methods for proteins.

    • Main Results:

    • Protein microarrays have been successfully developed for the serodiagnosis of allergic diseases.
    • These assays demonstrate good analytical and clinical performance.
    • Microarray assays offer advantages in convenience and cost compared to traditional ELISA formats.

    Conclusions:

    • Protein microarray technology presents a viable solution for overcoming limitations in current allergy serodiagnosis.
    • Allergen microarrays enable efficient, multi-allergen determination, improving diagnostic capabilities.
    • This technology facilitates timely and cost-effective serum profiling for allergic conditions.